Blood Irradiation Market Forecast to 2028

Report Code : TIPRE00003256 | Region : Global | Industry : Medical Device | Published Date : 27/Jul/2022
Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, and Others), and End User (Hospitals, Blood Banks, Diagnostics Clinics, and Research Institutes)

The blood irradiation market is projected to reach US$ 104.37 million by 2028 from US$ 65.15 million in 2021; it is expected to grow at a CAGR of 7.0% from 2022 to 2028.

The increase in communicable and noncommunicable diseases prevalence and rise in healthcare expenditure and government initiatives are among the factors driving the market growth. There is an increase in the number of incidence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, owing to a large population across the world susceptible to such conditions. According to World Health Organization (WHO), cardiovascular disorders are the leading cause of death globally, and ~17.9 million deaths are reported yearly. Additionally, the rising prevalence of communicable diseases, such as Hepatitis, influenza, Human Immunodeficiency Virus (HIV), and acquired immunodeficiency syndrome (AIDS), are driving the growth of the blood irradiation market. According to WHO, 325 million people were infected with the hepatitis B virus in 2020, and 900,000 people die from hepatitis B virus infection every year. Moreover, a large geriatric population across the world is contributing to the prevalence of noncommunicable diseases, such as cardiovascular disorders, renal disorders, and strokes. According to WHO, the population of people aged 60 years and above was 1 billion in 2019 and is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is susceptible to noncommunicable disease conditions owing to various factors such as poor nutrition, lack of physical activity, excessive use of tobacco, and consumption of alcohol.

Additionally, surging blood transfusion owing to an increase in surgical procedures, accidents, trauma cases, and disorders, along with the rising prevalence of bloodstream infections, supports the market growth. Bloodstream infections, underlying conditions, and invasive procedures are common among the geriatric population. Bloodstream infections are the major cause of illness and death among large populations. According to the National Library of Medicine, ~28,000 bloodstream infections occur across the world annually. Moreover, rising awareness about bloodstream infections and increasing immune responses to transfused blood can cause complications as increasing use of irradiated blood in cancer treatment strengthens the immune system and improves overall health of patients, which is driving the growth of the blood irradiation market.

Thus, the increase in prevalence of communicable and noncommunicable disorders, rise in blood transfusion, surge in bloodstream infections, and increase in immune responses are driving the growth of the blood irradiation market.

Increasing immunocompromised population and rising leukemia and lymphoma cases are expected to create ample opportunities for the blood irradiation market in the coming years. According to American Medical Association, in 2021, around 2.7% of the US adult population, ~7 million people, were immunocompromised, due to organ transplants, cancer, and autoimmune disorders. As per the National Institute of Environmental Health Sciences, autoimmune disorders affected more than 24 million population in the US in 2021, and their prevalence rate ranges from 5 to 8%. Additionally, the rising prevalence of cancer and tumors increased the use of chemotherapy and other treatments that negatively affect an individual's immune system. According to World Cancer Research Fund International, 18.1 million cancer cases were diagnosed in 2020, of which 9.3 million were men and 8.8 million were women.

Moreover, there has been significant growth in leukemia and lymphoma incidence rates across the world. According to Leukemia and Lymphoma Society, an estimated total of 186,400 people in the US were diagnosed with leukemia, lymphoma, or myeloma in 2021, and new cases of leukemia, lymphoma, and myeloma are accounted for 9.8% of the estimated 1,898,160 new cancer cases in 2021. Thus, a significant increase in the immunocompromised population and the rising prevalence of autoimmune disorders are expected to create ample opportunities for the blood irradiation market growth in the coming years.

Blood irradiators are a major requirement in the healthcare industry. Hence, researchers have been carrying out research & development activities, which have resulted in product innovations.

For instance, in November 2018, JW Bioscience, a subsidiary of JW Pharmaceutical, launched Sangray developed by Hitachi. Sangray is a medical device used to prevent transfusion-related graft-versus-host disease by irradiating a blood bag for transfusion with X-rays. It is also Korea’s first blood radiation device that does not use Cesium-137, which is a hazardous radioactive substance.

There have been advancements in alternative technologies, such as proton and ion beam therapies, that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues. Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors. These technological advancements and developments have a high precision rate with reduced side effects, likely to create ample opportunities for the blood irradiation market in the coming years. Thus, an increase in technological advancements, rise in product launches, and the surge in the use of alternative technologies are expected to support the growth of the market in the coming years..

Further, rising partnerships and collaborations of blood centers and huge companies drive the growth of the blood irradiators market.

Geography-Based Insights

North America held the largest share of the blood irradiation market in 2021. The US held the largest market share in North America. Advanced healthcare infrastructure, easy accessibility to medical facilities, and rising emphasis on improving treatment outcomes are expected to accelerate the growth of the market during the forecast period.

Asia Pacific is expected to witness the highest growth in the global blood irradiation market during the forecast period. In the coming years, the market is the region is expected to grow significantly in China, Japan, India, and other countries. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region would hold huge potential for the blood irradiation market players to grow during the forecast period.

Type-Based Insights

The blood irradiation market, based on type, is segmented into intravenous laser blood irradiation , transcutaneous laser blood irradiation,and extracorporeal blood irradiation. In 2021, the intravenous laser blood irradiation segment accounted for the largest market share. However, the extracorporeal laser blood irradiation segment is expected to register the highest CAGR of 7.8% during the forecast period.

End User-Based Insights

Based on end user, the blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospitals segment held the largest market share in 2021. However, the blood banks segment is estimated to register the highest CAGR of 7.7% in the market during the forecast period.

Indication-Based Insights

By indication, the blood irradiation market is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment held the largest market share in 2021. However, the lymphoma segment is estimated to register the highest CAGR of 8.8% in the market during the forecast period.

.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Eurostat are a few secondary sources referred to while preparing the report on the blood irradiation market.

The List of Companes - Blood Irradiation Market

1. Typenex Medical, LLC

2. Hitachi Medical Systems

3. Rad Source Technologies

4. Gilardoni S.p.A.

5. Gamma-Service Medical GmbH

6. Actemium

7. Best Theratronics Ltd.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Blood Irradiation Market – By Type

1.3.2 Global Blood Irradiation Market – By Indication

1.3.3 Global Blood Irradiation Market – By End User

1.3.4 Global Blood Irradiation Market – By Geography

2. Blood Irradiation Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Blood Irradiation Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Blood Irradiation Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Communicable and Noncommunicable Diseases

5.1.2 Rise in Healthcare Expenditure and Government Initiatives

5.2 Market Restraints

5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation

5.3 Market Opportunities

5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia And Lymphoma

5.4 Future Trends

5.4.1 Technological Advancements And Product Launches

5.5 Impact Analysis

6. Blood Irradiation Market– Global Analysis

6.1 Global Blood Irradiation Market Revenue Forecasts and Analysis

6.1.1 Overview

6.1.2 Global Blood Irradiation Market, and Forecast to 2028 (Units)

6.1.3 Global Blood Irradiation Market, By Geography - Forecasts and Analysis

6.1.4 Global Blood Irradiation Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance Of Key Players

6.2.5 Hitachi Medical Systems

6.2.6 Best Theratronics

7. Blood Irradiation Market Analysis – By Type

7.1 Overview

7.2 Blood Irradiation Market Revenue Share, by Type (2021 and 2028)

7.3 Intravenous Laser Blood Radiation

7.3.1 Overview

7.3.2 Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Transcutaneous Laser Blood Radiation

7.4.1 Overview

7.4.2 Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Extracorporeal Blood Radiation

7.5.1 Overview

7.5.2 Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

8. Blood Irradiation Market –By End User

8.1 Overview

8.2 Blood Irradiation Market, by End User, 2021 and 2028 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Blood Banks

8.4.1 Overview

8.4.2 Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Diagnostic Centers

8.5.1 Overview

8.5.2 Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Research Institutes

8.6.1 Overview

8.6.2 Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9. Blood Irradiation Market –By Indication

9.1 Overview

9.2 Blood Irradiation Market, by Indication, 2021 and 2028 (%)

9.3 Acute Leukemia

9.3.1 Overview

9.3.2 Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Solid Tumors

9.4.1 Overview

9.4.2 Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pelvic Tumors

9.5.1 Overview

9.5.2 Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Lymphoma

9.6.1 Overview

9.6.2 Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10. Global Blood Irradiation Market – Geographic Analysis

10.1 North America: Blood Irradiation Market

10.1.1 Overview

10.1.2 North America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.1.4 North America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.1.5 North America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.1.6 North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.1.6.1.4 US: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.1.6.1.5 US: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.1.6.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.1.6.2.5 Canada: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.1.6.3.5 Mexico: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2 Europe: Blood Irradiation Market

10.2.1 Overview

10.2.2 Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.4 Europe: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.5 Europe: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6 Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.1.4 Germany: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.1.5 Germany: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6.2 UK: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 UK: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 UK: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.2.4 UK: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.2.5 UK: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6.3 France: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 France: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 France: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.3.4 France: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.3.5 France: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6.4 Italy: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.4.4 Italy: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.4.5 Italy: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6.5 Spain: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.5.4 Spain: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.5.5 Spain: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.2.6.6 Rest of Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3 Asia Pacific: Blood Irradiation Market

10.3.1 Overview

10.3.2 Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.4 Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.5 Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6 Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)

10.3.6.1 China Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.3 China: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.1.4 China: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.1.5 China: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6.2 Japan Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.3 Japan: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.2.4 Japan: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.2.5 Japan: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6.3 India Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.3 India: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.3.4 India: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.3.5 India: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6.4 South Korea Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.3 South Korea: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.4.4 South Korea: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.4.5 South Korea: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6.5 Australia Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.3 Australia: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.5.4 Australia: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.5.5 Australia: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.4 Middle East & Africa Blood Irradiation Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.4.4 Middle East & Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

10.4.5 Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.4.6 Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)

10.4.6.1 Saudi Arabia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 Saudi Arabia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.3 Saudi Arabia: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.4.6.1.4 Saudi Arabia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.5 Saudi Arabia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2 UAE: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 UAE: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.3 UAE: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.4.6.2.4 UAE Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.5 UAE Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3 South Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 South Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.3 South Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.4.6.3.4 South Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.5 South Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4 Rest of Middle East & Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East & Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.4.6.4.5 Rest of Middle East & Africa: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.5 South and Central America Blood Irradiation Market Revenue and Forecasts To 2028

10.5.1 Overview

10.5.2 South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.5.4 South and Central America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.5.5 South and Central America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.5.6 South and Central America: Blood Irradiation Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Brazil: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 Brazil: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.5.6.1.4 Brazil: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.5.6.1.5 Brazil: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.5.6.2 Argentina: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 Argentina: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 Argentina: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.5.6.2.4 Argentina: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.5.6.2.5 Argentina: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3 Rest of South and Central America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)

10.5.6.3.4 Rest of South and Central America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)

10.5.6.3.5 Rest of South and Central America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Global Blood Irradiation Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Blood Irradiation Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Blood Irradiation Market, 2021-2028

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Hitachi, Ltd.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Best Theratronics Ltd.,

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Rad Source Technologies

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Gilardoni S.p.A.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Gamma-Service Medical GmbH

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Typenex Medical

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Actemium

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. Global Blood Irradiation Market– Volume and Forecast to 2028 (Units)

Table 2. North America Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 14. Europe Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 16. Europe Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 17. Germany Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Germany: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 19. Germany Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 20. UK Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. UK: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 22. UK Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 23. France Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 24. France: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 25. France Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 28. Italy Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 34. Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 35. Asia Pacific: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 36. Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 37. China Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 38. China Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 39. China Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 40. Japan Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 41. Japan Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 42. Japan Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 43. India Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 44. India Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 45. India Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 46. South Korea Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 47. South Korea Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 48. South Korea Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 49. Australia Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 50. Australia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 51. Australia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Asia Pacific Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 55. Middle East & Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 56. Middle East & Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 57. Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 58. Saudi Arabia Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 59. Saudi Arabia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 60. Saudi Arabia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 61. UAE Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 62. UAE Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 63. UAE Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 64. South Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 65. South Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 66. South Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 67. Rest of Middle East & Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 68. Rest of Middle East & Africa Blood Irradiation Market, by End-Users– Revenue and Forecast to 2028 (US$ Million)

Table 69. Rest of Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 70. South and Central America: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 71. South and Central America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 72. South and Central America: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 73. Brazil: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 74. Brazil: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 75. Brazil: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 76. Argentina: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 77. Argentina: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 78. Argentina: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 79. Rest of South and Central America: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 80. Rest of South and Central America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)

Table 81. Rest of South and Central America: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 82. Recent Inorganic Growth Strategies in the Blood Irradiation Market

Table 83. Recent Organic Growth Strategies in the Blood Irradiation Market

Table 84. Glossary of Terms, Blood Irradiation Market

The List of Companes - Blood Irradiation Market

1. Typenex Medical, LLC

2. Hitachi Medical Systems

3. Rad Source Technologies

4. Gilardoni S.p.A.

5. Gamma-Service Medical GmbH

6. Actemium

7. Best Theratronics Ltd.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the blood irradiation market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the global blood irradiation market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Blood Irradiation Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry